大麻成分, テトラヒドロカンナビノール, カンナビジオール及び活性代謝物とシンナー及びその含有成分との相互作用

概要

論文の詳細を見る
The interaction of cannabinoids, tetrahydrocannabinol (THC), cannabidiol (CBD) and some active metabolites with thinner and its components was studied in mice and the following results were obtained. 1) Δ^9-THC but not CBD (5 mg/kg, i.v.) significantly prolonged thinner-induced anesthesia by 1.8 fold. The latent period to induce the anesthesia was significantly shortened by Δ^9-THC. 2) 11-Hydroxy-Δ^8-THC and 11-oxo-Δ^8-THC (5 mg/kg, i.v.), which are active metabolites of Δ^8-THC, significantly prolonged thinner-induced anesthesia by 2.0 and 3.2 fold, respectively. 11-Oxo-Δ^8-THC significantly shortened latent period to induce the anesthesia. 3) Among cannabinoids examined, only 11-hydroxy-Δ^8-THC significantly prolonged toluene-induced anesthesia by 2.4 fold. Thinner contains about 60% of toluene and a small amount of ethyl acetate, ethylether and ethylalcohol. 4) Δ^8-THC and its active metabolites, 11-hydroxy-Δ^8-THC and 11-oxo-Δ^8-THC significantly prolonged ethyl acetate-induced anesthesia by 4.4,4.9 and 5.1 fold, respectively. Moreover, Δ^8-THC, 11-hydroxy-Δ^8-THC and 11-oxo-Δ^8-THC significantly shortened latent period to induce anesthesia.
公益社団法人日本薬学会の論文
1988-12-31